2023 annual financial data
Kalaris Therapeutics 2023 Net income growth
Direct answer
Net income growth was 5.08%.
Operating income was -13,464,000 USD and net income was -14,699,000 USD.
Operating cash flow was -14,132,000 USD.
Get free Kalaris Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,464,000 USD
- Net income
- -14,699,000 USD
- Operating cash flow
- -14,132,000 USD